Skip to main content

CORRECTION article

Front. Immunol., 08 December 2022
Sec. Vaccines and Molecular Therapeutics
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1103893
This article is part of the Research Topic Advancing the Understanding of Emergence of SARS-CoV-2 Genetic Variants and COVID-19 Vaccine Efficacy: Essential Clinical and Molecular Insights and Breakthroughs View all 39 articles

Corrigendum: Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses

This article is a correction to:

  1. Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses

    1. Read original article
Bo-Seong JeongBo-Seong Jeong1Joon Young JeonJoon Young Jeon2Chih-Jen LaiChih-Jen Lai3Hye-Yeoung YunHye-Yeoung Yun4Jae U. Jung*Jae U. Jung3*Byung-Ha Oh,*Byung-Ha Oh1,2*
  • 1Department of Biological Sciences, KAIST Institute for the Biocentury, Korea Advanced Institute of Science and Technology, Daejeon, South Korea
  • 2Department of Protein Design, Therazyne, lnc., Daejeon, South Korea
  • 3Cancer Biology Department, Infection Biology Program, and Global Center for Pathogen and Human Health Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States
  • 4New Target Team, Promedigen, lnc., Daejeon, South Korea

A Corrigendum on
Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses

doi: 10.3389/fimmu.2022.1049867

In the published article, there was an error in the Funding statement. An incorrect grant number was given for the National Research Foundation grant received by author B-HO. The correct Funding statement appears below.

“This work was supported by the National Research Foundation grant (NRF-2020R1A4A3079755 to B-HO) through the Korean government (MSIP) and CA200422, CA251275, AI140718, AI140705, AI140705-03S1, AI152190, AI171201, DE023926, DE028521, and Korea Research Institute of Bioscience and Biotechnology Research Initiative Program KGM9942012 to JUJ.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, viral evolution, key epitope, computational affinity maturation, broadly neutralizing antibody, broad-spectrum vaccine

Citation: Jeong B-S, Jeon JY, Lai C-J, Yun H-Y, Jung JU and Oh B-H (2022) Corrigendum: Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses. Front. Immunol. 13:1103893. doi: 10.3389/fimmu.2022.1103893

Received: 21 November 2022; Accepted: 22 November 2022;
Published: 08 December 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Jeong, Jeon, Lai, Yun, Jung and Oh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Byung-Ha Oh, bhoh@kaist.ac.kr; Jae U. Jung, jungj@ccf.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.